Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversidade Federal Fluminense
About this trial
The objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with CKD stages 3-5 under conservative management
Disqualifiers
pregnant,
lactating,
smoker
patients using antibiotics and antioxidant supplements in the last three months
Trial design
Design model
Parallel
Treatments tested in this trial
Red Propolis
Dietary supplementParticipants will receive 200mg of red propolis capsules per day for two months.
Placebo Control
Other interventionParticipants will receive 200mg of placebo capsules per day for two months.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Red Propolis GroupExperimental treatment 1 intervention
Group B: Placebo GroupPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in inflammatory biomarkers
Changes in the IL-6 and TNF-α
Time frame
8 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov